ZIRANU, PINA
 Distribuzione geografica
Continente #
EU - Europa 30.888
NA - Nord America 836
AS - Asia 222
AF - Africa 2
SA - Sud America 1
Totale 31.949
Nazione #
IT - Italia 30.659
US - Stati Uniti d'America 821
CN - Cina 114
SE - Svezia 95
SG - Singapore 65
DE - Germania 26
FI - Finlandia 22
GB - Regno Unito 18
IE - Irlanda 14
IN - India 13
FR - Francia 12
VN - Vietnam 12
CA - Canada 11
NL - Olanda 11
UA - Ucraina 11
KR - Corea 7
BE - Belgio 5
AT - Austria 4
ES - Italia 4
HK - Hong Kong 4
BZ - Belize 3
IL - Israele 2
JP - Giappone 2
MU - Mauritius 2
RO - Romania 2
RU - Federazione Russa 2
BR - Brasile 1
CZ - Repubblica Ceca 1
IR - Iran 1
KZ - Kazakistan 1
LU - Lussemburgo 1
PT - Portogallo 1
TR - Turchia 1
TT - Trinidad e Tobago 1
Totale 31.949
Città #
Cagliari 29.316
Uta 1.175
Fairfield 100
Boardman 93
Nyköping 83
Chandler 78
Ashburn 54
Houston 52
Seattle 47
Singapore 42
Wilmington 41
Woodbridge 40
New York 36
Santa Clara 32
Cambridge 31
Rome 22
Shanghai 22
Helsinki 21
Dearborn 16
Boston 14
Beijing 12
Dong Ket 12
London 11
Toronto 11
Ann Arbor 10
Los Angeles 10
Pune 10
Jacksonville 9
San Diego 9
Dublin 8
Amsterdam 7
Paris 7
Seoul 7
Guangzhou 6
Wuhan 6
Boulder 5
Centro 5
Menlo Park 5
Milan 5
Nanjing 5
Shenzhen 5
Buffalo 4
Hong Kong 4
La Maddalena 4
Munich 4
Naples 4
Sestu 4
Vienna 4
Belize City 3
Pamplona 3
Piscataway 3
Riese Pio X 3
San Cipriano d'Aversa 3
Sassari 3
Torino 3
Turin 3
Zhengzhou 3
Andover 2
Augusta 2
Enna 2
Godo 2
Hangzhou 2
Hefei 2
Jiaxing 2
Leuven 2
Livorno 2
Molenbeek-Saint-Jean 2
Moscow 2
Nanchang 2
Norwalk 2
Olbia 2
Phoenix 2
Redwood City 2
Romainville 2
Salerno 2
San Giorgio a Cremano 2
Selargius 2
Sindelfingen 2
Wuxi 2
Xian 2
Alexandria 1
Almaty 1
Assèmini 1
Bergamo 1
Berlin 1
Borås 1
Brno 1
Brussels 1
Cavenago di Brianza 1
Changsha 1
Chicago 1
Chongqing 1
Clifton 1
Council Bluffs 1
Ebisu 1
Edinburgh 1
Frankfurt am Main 1
Frattamaggiore 1
Gela 1
Hamburg 1
Totale 31.601
Nome #
Clustered protocadherins methylation alterations in cancer 3.192
BRAF-mutant colorectal cancer, a different breed evolving 3.153
Molecular-biology-driven treatment for metastatic colorectal cancer 2.641
HOXD8 hypermethylation as a fully sensitive and specific biomarker for biliary tract cancer detectable in tissue and bile samples 2.555
Colorectal cancer early detection in stool samples tracing CPG islands methylation alterations affecting gene expression 2.232
The role of primary tumour sidedness, EGFR gene copy number and EGFR promoter methylation in RAS/BRAF wild-type colorectal cancer patients receiving irinotecan/cetuximab 2.068
Prognostic Value of Thyroid Hormone Ratios in Patients With Advanced Metastatic Colorectal Cancer Treated With Regorafenib: The TOREADOR Study 2.023
A validated prognostic classifier for V600EBRAF-mutated metastatic colorectal cancer: the 'BRAF BeCool' study 1.775
Immunotherapy and Cancer: The Multi-Omics Perspective 1.468
Why precision medicine should be applied across the continuum of care for metastatic colorectal cancer patients? 1.425
Molecular-driven treatment for biliary tract cancer: the promising turning point 1.105
Colorectal cancer promoter methylation alteration affects the expression of glutamate ionotropic receptor AMPA type subunit 4 alternative isoforms potentially relevant in colon tissue 919
Neoadjuvant chemo-radiotherapy response in patients affected by mismatch repair deficient (dMMR) locally advanced rectal cancer 869
Liquid Biopsy-Driven Cetuximab Rechallenge Strategy in Molecularly Selected Metastatic Colorectal Cancer Patients 816
Balance between the stem cell marker CD44 and CDX2 expression in colorectal cancer 813
Corrigendum: Why precision medicine should be applied across the continuum of care for metastatic colorectal cancer patients 670
New Horizons in Metastatic Colorectal Cancer: Prognostic Role of CD44 Expression 613
Uncovering key targets of success for immunotherapy in pancreatic cancer 596
Circulating tumour DNA in gastrointestinal cancer in clinical practice: Just a dream or maybe not? 577
The role of immune checkpoint inhibitors in the treatment sequence of advanced gastric or gastro-esophageal junction cancer: A systematic review and meta-analysis of randomized trials 545
Correction to: Angiogenesis Genotyping and Clinical Outcomes in Patients with Advanced Hepatocellular Carcinoma Receiving Sorafenib: The ALICE‑2 Study 413
Prediction of Response to Anti-Angiogenic Treatment for Advanced Colorectal Cancer Patients: From Biological Factors to Functional Imaging 407
Patients with early-onset metastatic colorectal cancer as an emerging distinctive clinical and molecular phenomenon 313
A new prognostic score for biliary tract cancer: a multicenter experience 132
REINVENT (REgorafenIb traNslational eValuation angiogENesis proTocol) 127
CD44: A New Prognostic Marker in Colorectal Cancer? 101
Fentanyl pectin nasal spray for breakthrough cancer pain treatment: a single center experience 94
Medical management of malignant bowel obstruction: our center experience 93
Thyroid dysfunction and immune checkpoint inhibitors: Effect on survival in elderly patients 91
Overall survival and progression-free survival in metastatic colorectal cancer patients with concomitant RAS and BRAF mutations: a single center experience 91
Mismatch repair proteins (MMR) expression as predictive factor in locally advanced rectal cancer 85
Early taxane exposure and neurotoxicity in breast cancer patients 44
Totale 32.046
Categoria #
all - tutte 41.170
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 41.170


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.894 0 0 0 0 0 993 501 78 43 74 71 134
2020/20217.262 151 268 227 2.305 1.352 864 351 494 204 426 385 235
2021/20222.350 196 120 63 131 142 126 101 128 218 252 312 561
2022/20233.974 319 654 564 307 286 357 175 306 275 290 290 151
2023/20245.431 233 115 136 192 296 560 565 2.165 169 229 374 397
2024/20259.252 3.026 3.284 1.030 1.034 484 394 0 0 0 0 0 0
Totale 32.046